Published in J Urol on April 01, 2003
Autonomic dysfunction in multiple sclerosis. J Neurol (2006) 1.01
Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice. Ther Adv Neurol Disord (2011) 0.94
Neurogenic Causes of Detrusor Underactivity. Curr Bladder Dysfunct Rep (2015) 0.81
Symptomatic therapy in multiple sclerosis. Ther Adv Neurol Disord (2011) 0.79
Management of neurogenic bladder in patients with multiple sclerosis. Nat Rev Urol (2016) 0.78
Micturitional disturbance due to bilateral medial frontal lobe lesions in a patient with multiple sclerosis. Neurol Sci (2010) 0.77
Detrusor sphincter dyssynergia: a review of physiology, diagnosis, and treatment strategies. Transl Androl Urol (2016) 0.77
Secondary and tertiary treatments for multiple sclerosis patients with urinary symptoms. Investig Clin Urol (2016) 0.75
Evaluation of lower urinary tract symptoms in multiple sclerosis patients: Review of the literature and current guidelines. Can Urol Assoc J (2017) 0.75
Intradetrusorial Botulinum Toxin in Patients with Multiple Sclerosis: A Neurophysiological Study. Toxins (Basel) (2015) 0.75
Botulinum neurotoxin-A treatment of lower urinary tract symptoms in multiple sclerosis. Can Urol Assoc J (2014) 0.75
Clinical Characteristics and Urodynamic Analysis of Urinary Dysfunction in Multiple Sclerosis. Chin Med J (Engl) (2016) 0.75
Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature (2006) 24.39
The role of autophagy during the early neonatal starvation period. Nature (2004) 22.40
In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell (2003) 17.55
Activation of ERBB2 signaling causes resistance to the EGFR-directed therapeutic antibody cetuximab. Sci Transl Med (2011) 4.51
LC3, an autophagosome marker, can be incorporated into protein aggregates independent of autophagy: caution in the interpretation of LC3 localization. Autophagy (2007) 3.91
Symptom assessment tool for overactive bladder syndrome--overactive bladder symptom score. Urology (2006) 2.63
Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation. Exp Neurol (2004) 1.66
The TRPV4 cation channel mediates stretch-evoked Ca2+ influx and ATP release in primary urothelial cell cultures. J Biol Chem (2009) 1.61
Diagnostic accuracy of the 13C-urea breath test for childhood Helicobacter pylori infection: a multicenter Japanese study. Am J Gastroenterol (2002) 1.60
Phase III, randomised, double-blind, placebo-controlled study of the β3-adrenoceptor agonist mirabegron, 50 mg once daily, in Japanese patients with overactive bladder. BJU Int (2014) 1.57
Malignant syndrome in Parkinson's disease: concept and review of the literature. Parkinsonism Relat Disord (2003) 1.57
The prevalence of Helicobacter pylori in Japanese children with gastritis or peptic ulcer disease. J Gastroenterol (2004) 1.50
Dystonia in a 13-year-old boy with secondary progressive multiple sclerosis. Brain Dev (2004) 1.40
Small in-frame deletion in the epidermal growth factor receptor as a target for ZD6474. Cancer Res (2004) 1.39
A newly developed small-caliber videoduodenoscope for endoscopic retrograde cholangiopancreatography in children. J Clin Gastroenterol (2003) 1.39
Autophagic cell death of pancreatic acinar cells in serine protease inhibitor Kazal type 3-deficient mice. Gastroenterology (2005) 1.38
Clinical features of neuromyelitis optica in a large Japanese cohort: comparison between phenotypes. J Neurol Neurosurg Psychiatry (2011) 1.32
Antibiotic resistance of Helicobacter pylori strains in Japanese children. J Clin Microbiol (2002) 1.32
Clinical guidelines for overactive bladder. Int J Urol (2009) 1.27
Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients. Breast Cancer Res Treat (2006) 1.25
Suppression of synaptic plasticity by cerebrospinal fluid from anti-NMDA receptor encephalitis patients. Neurobiol Dis (2011) 1.13
Switching addictions between HER2 and FGFR2 in HER2-positive breast tumor cells: FGFR2 as a potential target for salvage after lapatinib failure. Biochem Biophys Res Commun (2011) 1.13
Nitric oxide-mediated regulation of connexin43 expression and gap junctional intercellular communication in mesangial cells. J Am Soc Nephrol (2004) 1.12
A collaborative study on the malignant syndrome in Parkinson's disease and related disorders. Parkinsonism Relat Disord (2003) 1.11
Differential expression profile of cold (TRPA1) and cool (TRPM8) receptors in human urogenital organs. Urology (2008) 1.10
Endovascular treatment of ureteroarterial fistulas with stent-grafts. Radiat Med (2008) 1.08
Transient receptor potential channel A1 involved in sensory transduction of rat urinary bladder through C-fiber pathway. Urology (2007) 1.07
Suppression of NF-kappaB by cyclosporin a and tacrolimus (FK506) via induction of the C/EBP family: implication for unfolded protein response. J Immunol (2009) 1.05
Interleukin-2 potentiation of cetuximab antitumor activity for epidermal growth factor receptor-overexpressing gastric cancer xenografts through antibody-dependent cellular cytotoxicity. Cancer Sci (2008) 1.05
Clinical efficacy of istradefylline (KW-6002) in Parkinson's disease: a randomized, controlled study. Mov Disord (2010) 1.05
Assessment of overactive bladder symptoms: comparison of 3-day bladder diary and the overactive bladder symptoms score. Urology (2010) 1.05
Solifenacin as add-on therapy for overactive bladder symptoms in men treated for lower urinary tract symptoms--ASSIST, randomized controlled study. Urology (2011) 1.01
Rapid, transient induction of ER stress in the liver and kidney after acute exposure to heavy metal: evidence from transgenic sensor mice. FEBS Lett (2007) 0.99
Accuracy of the stool antigen test for the diagnosis of childhood Helicobacter pylori infection: a multicenter Japanese study. Am J Gastroenterol (2003) 0.98
Overexpression of epithelial sodium channels in epithelium of human urinary bladder with outlet obstruction. Urology (2004) 0.98
Central nervous system safety of anticholinergic drugs for the treatment of overactive bladder in the elderly. Clin Ther (2005) 0.97
Association of the expression of mutant epidermal growth factor receptor protein as determined with mutation-specific antibodies in non-small cell lung cancer with progression-free survival after gefitinib treatment. J Thorac Oncol (2012) 0.97
Association between gastric atrophy and Helicobacter pylori infection in Japanese children: a retrospective multicenter study. Dig Dis Sci (2006) 0.97
Prevention and treatment of malignant syndrome in Parkinson's disease: a consensus statement of the malignant syndrome research group. Parkinsonism Relat Disord (2003) 0.97
Neuroprotection and enhanced recovery with edaravone after acute spinal cord injury in rats. Spine (Phila Pa 1976) (2005) 0.96
The methylentetrahydrofolate reductase C677T point mutation is a risk factor for vascular access thrombosis in hemodialysis patients. Am J Kidney Dis (2003) 0.96
Degeneration of dementia with Lewy bodies measured by diffusion tensor imaging. NMR Biomed (2009) 0.95
Continuous, noninvasive monitoring of local microscopic inflammation using a genetically engineered cell-based biosensor. Lab Invest (2005) 0.93
Metastatic uveal tumor secondary to testicular choriocarcinoma. Jpn J Ophthalmol (2004) 0.93
Increase of antioxidative potential by tert-butylhydroquinone protects against cell death associated with 6-hydroxydopamine-induced oxidative stress in neuroblastoma SH-SY5Y cells. Brain Res Mol Brain Res (2003) 0.93
Human muscarinic receptor binding characteristics of antimuscarinic agents to treat overactive bladder. J Urol (2006) 0.92
Ejaculation disorder is associated with increased efficacy of silodosin for benign prostatic hyperplasia. Urology (2010) 0.92
Tolerability of nintedanib (BIBF 1120) in combination with docetaxel: a phase 1 study in Japanese patients with previously treated non-small-cell lung cancer. J Thorac Oncol (2015) 0.92
DRESSA: biosensing of dioxin and dioxin-like chemicals using secreted alkaline phosphatase. Anal Biochem (2004) 0.92
Amantadine for dyskinesias in Parkinson's disease: a randomized controlled trial. PLoS One (2010) 0.92
Nationwide survey of acute juvenile female non-herpetic encephalitis in Japan: relationship to anti-N-methyl-D-aspartate receptor encephalitis. Intern Med (2009) 0.92
Involvement of hypoxia-triggered endoplasmic reticulum stress in outlet obstruction-induced apoptosis in the urinary bladder. Lab Invest (2008) 0.92
Amiloride-sensitive ion channels in urinary bladder epithelium involved in mechanosensory transduction by modulating stretch-evoked adenosine triphosphate release. Urology (2007) 0.91
The effect of tau genotype on clinical features in FTDP-17. Parkinsonism Relat Disord (2005) 0.91
Influence of a tumor necrosis factor gene polymorphism in Japanese patients with multiple system atrophy. Neurosci Lett (2005) 0.90
Multicenter comparison of rapid lateral flow stool antigen immunoassay and stool antigen enzyme immunoassay for the diagnosis of Helicobacter pylori infection in children. Helicobacter (2004) 0.89
Synergistic effects of PDGF-BB and cAMP-elevating agents on expression of connexin43 in mesangial cells. Am J Physiol Renal Physiol (2005) 0.89
Real-time monitoring of mesangial cell-macrophage cross-talk using SEAP in vitro and ex vivo. Kidney Int (2005) 0.89
Selection of autophagy or apoptosis in cells exposed to ER-stress depends on ATF4 expression pattern with or without CHOP expression. Biol Open (2013) 0.88
Roles of mechanosensitive ion channels in bladder sensory transduction and overactive bladder. Int J Urol (2008) 0.88
Reciprocal regulation between proinflammatory cytokine-induced inducible NO synthase (iNOS) and connexin43 in bladder smooth muscle cells. J Biol Chem (2011) 0.88
Sex-related differences in activity of lower urinary tract in response to intravesical acid irritation in decerebrate unanesthetized mice. Am J Physiol Regul Integr Comp Physiol (2008) 0.88
Effects of urethane on reflex activity of lower urinary tract in decerebrate unanesthetized rats. Am J Physiol Renal Physiol (2012) 0.87
Treatment of abdominal malignancy invading the vena cava: a report of seven cases. Surg Today (2007) 0.87
Sex differences in the expression profile of acid-sensing ion channels in the mouse urinary bladder: a possible involvement in irritative bladder symptoms. BJU Int (2009) 0.87
Contribution of the interleukin-1beta gene polymorphism in multiple system atrophy. Mov Disord (2002) 0.87
Profiling of functional phosphodiesterase in mesangial cells using a CRE-SEAP-based reporting system. Br J Pharmacol (2006) 0.87
Brain-derived neurotrophic factor gene polymorphisms in Japanese patients with sporadic Alzheimer's disease, Parkinson's disease, and multiple system atrophy. Mov Disord (2005) 0.87
Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer. Int J Urol (2006) 0.87
Transplantation of side population cells restores the function of damaged exocrine glands through clusterin. Stem Cells (2012) 0.87
Dopaminergic mechanisms controlling urethral function in rats. Neurourol Urodyn (2006) 0.87
Efficacy and safety of extended- versus immediate-release pramipexole in Japanese patients with advanced and L-dopa-undertreated Parkinson disease: a double-blind, randomized trial. Clin Neuropharmacol (2012) 0.86
Influence of monocyte chemoattractant protein 1 gene polymorphism on age at onset of sporadic Parkinson's disease. Mov Disord (2003) 0.86
Ropinirole is effective on motor function when used as an adjunct to levodopa in Parkinson's disease: STRONG study. Mov Disord (2007) 0.86
Relevance of distinct monocyte subsets to clinical course of ischemic stroke patients. PLoS One (2013) 0.85
Suppression of bladder overactivity by adenosine A2A receptor antagonist in a rat model of Parkinson disease. J Urol (2012) 0.85
Expression changes in arrestin β 1 and genetic variation in catechol-O-methyltransferase are biomarkers for the response to morphine treatment in cancer patients. Oncol Rep (2012) 0.85
Association between interleukin-6 gene polymorphism and human T-cell leukemia virus type I associated myelopathy. Hum Immunol (2002) 0.84
Clinical course and prognosis of 27 patients with childhood onset multiple sclerosis in Japan. Brain Dev (2005) 0.84
A novel mass spectrometry-based assay for diagnosis of EML4-ALK-positive non-small cell lung cancer. J Thorac Oncol (2012) 0.84
Nonsteroidal anti-inflammatory drug flufenamic acid is a potent activator of AMP-activated protein kinase. J Pharmacol Exp Ther (2011) 0.84
Prospective study evaluating the plasma concentrations of twenty-six cytokines and response to morphine treatment in cancer patients. Anticancer Res (2011) 0.84
Current and future directions in diagnostic markers in interstitial cystitis. Int J Urol (2003) 0.84
Gelatin hydrogel impregnated with platelet-rich plasma releasate promotes angiogenesis and wound healing in murine model. J Artif Organs (2014) 0.84
Functional roles of TRPV1 channels in lower urinary tract irritated by acetic acid: in vivo evaluations of the sex difference in decerebrate unanesthetized mice. Am J Physiol Renal Physiol (2010) 0.84
Incontinence and detrusor dysfunction associated with pelvic organ prolapse: clinical value of preoperative urodynamic evaluation. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.84
The effect of dopamine agonists: the expression of GDNF, NGF, and BDNF in cultured mouse astrocytes. J Neurol Sci (2010) 0.83
[A guideline for the treatment of Parkinson's disease]. Rinsho Shinkeigaku (2002) 0.83
Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes. Life Sci (2003) 0.83
Chemokine receptors associated with immunity within and outside the central nervous system in early relapsing-remitting multiple sclerosis. J Neuroimmunol (2002) 0.83
Intraperitoneal rupture of giant hydronephrosis due to ureteral cancer accompanied by renal cell carcinoma. J Urol (2002) 0.83
Randomized, double-blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease. Mov Disord (2003) 0.83
Immunological disturbances in the central nervous system linked to MRI findings in multiple sclerosis. J Neuroimmunol (2002) 0.83
5'-AMP-activated protein kinase attenuates adriamycin-induced oxidative podocyte injury through thioredoxin-mediated suppression of the apoptosis signal-regulating kinase 1-P38 signaling pathway. Mol Pharmacol (2013) 0.83
Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal pathway. Br J Pharmacol (2003) 0.83
Roles of adenosine A1 and A2A receptors in the control of micturition in rats. Neurourol Urodyn (2013) 0.83
Helicobacter heilmannii infection in a child after successful eradication of Helicobacter pylori: case report and review of literature. J Gastroenterol (2005) 0.82
Cabergoline stimulates synthesis and secretion of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor by mouse astrocytes in primary culture. Pharmacology (2004) 0.82